期刊文献+

西布曲明及其光学异构体的药理学研究概况 被引量:1

Pharmacological review of sibutramine and its optical isomers
下载PDF
导出
摘要 目的综述西布曲明及其光学异构体的药理学研究概况。方法根据近年来的文献 ,介绍了西布曲明的药代动力学特点、药理作用、临床研究、不良反应、毒理研究、药物相互作用及其旋光异构体以及代谢产物旋光异构体的药理特性。结果与结论西布曲明是一种治疗肥胖症的新型药物 ,其减肥作用已被实验研究和临床研究所证实 。 Objective To review the pharmacological study on sibutramine and its optical isomers.Methods According to the documents in recent years,this paper introduced the pharmacokinetic characterization,pharmacological effects,clinical study,adverse reactions,toxicological study and drug interaction of sibutramine.The pharmacological characterizations of its optical isomers and metabolites isomers were also summarized.Results and Conclusions Sibutamine is a novel anti obesity drug,and its anti obesity effects have been demonstrated by the experimental and clinical study.It needs further study on the pharmacology of its optical isomers.
出处 《沈阳药科大学学报》 CAS CSCD 2003年第3期222-225,共4页 Journal of Shenyang Pharmaceutical University
关键词 西布曲明 光学异构体 药理作用 综述 sibutramine optical isomers pharmacology review
  • 相关文献

参考文献15

  • 1George A, Bray. Medicinal strategies in the treatment of obesity [J]. Nature, 2000, 404(6) :672 - 677.
  • 2Garratt CJ, Hind ID, Haddock RE. Single/repeat dose kinetics of sibutramine metabolites in obeses subjecdts[J] .J Clin Pharmacol, 1995, 35(9) :928.
  • 3Wortley KE, Heal DJ, Stanford SC, et al. Modulation of sibutramine-induced increases in extracellular noradrenaline concentration in rat frontal, cortex and hypothalamus by α2-adrenoceptors [ J ]. Br J Pharmacol,1999, 128(3) :659 - 666.
  • 4Michael B, Chen B, Peter K, et al. Sibutramine reduces feeding, body fat and improves insulin resistance in dietary-obese male wistar rats independently of hypothalamic neuropeptide Y [J]. Br J Pharmacol, 2001,132(8) : 1898 - 1904.
  • 5Luque CA, Rey JA. The discovery and status of sibutramine as an anti-obesity drug [J]. Eur J Pharmacol,2002, 440(2 - 3) : 119 - 128.
  • 6Jackson HC, Needham AM, Hutchins LJ, et al. Comparison of the effects of sibutramine and other monoamine reuptake inhibitor on food intake on the rat[J]. Br J Pharmacol, 1997, 121(8) :301 - 308.
  • 7Jackson HC, Bearham MC, Hutchins LJ, et al. Investigation of mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat [ J ]. Br J Pharmacol,1997. 121(8): 1613 - 1618.
  • 8Grignasehi G, Fanelli E, Seagnol I, et al. Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigms in rats [ J].Br J Pharmaeol, 1999, 127(5) : 1190 - 1194.
  • 9Balcioglu A, Wurtman RJ. Sbutramine, a serotonin uptake inhibitor, increases dopamine concentration in rat striatal and hypothalamic extracellular fluid [ J ]. Neuropharmacology, 2000, 39 ( 12 ) : 2352 - 2359.
  • 10Connoley IP, Liu YL, Frost L, et al. Thermogenic effects of sibutramine and its metabolites [J]. Br J Pharmacol, 1999,126(6) : 1487- 1495.

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部